COMMUNIQUÉS West-GlobeNewswire

Vaccinex, Inc. to Present at the Oppenheimer & Co. 29th Annual Healthcare Conference on March 19, 2019
13/03/2019
ROCHESTER, N.Y., March 13, 2019 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Nasdaq: VCNX), a clinical-stage biotechnology company pioneering novel investigational antibody therapies in cancer and Huntington’s disease, today [...]
The 3D designed Conformis Hip System Announced at the 2019 AAOS conference
13/03/2019
Designed to enhance operational efficiency for the surgeon and improve patient outcomes, the Conformis Hip System is the most advanced, patient conforming hip replacement system available BILLERICA, Mass., March 13, [...]
Checkpoint Therapeutics Announces Issuance of Two New Patents for EGFR Inhibitor CK-101
13/03/2019
U.S. and European patent protections through at least August 2034 NEW YORK, March 13, 2019 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT), a clinical-stage immuno-oncology [...]
Mustang Bio to Present at Oppenheimer’s 29th Annual Healthcare Conference
13/03/2019
NEW YORK, March 13, 2019 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a company focused on the development of novel immunotherapies based on proprietary chimeric antigen receptor engineered T cell ( [...]
Daxor Corporation to Showcase Reduction in Mortality and Hospital Readmissions with BVA-100® Guided-Care at the Annual Meeting of the American College of Cardiology Expo 2019
13/03/2019
NEW YORK, March 13, 2019 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR) an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measurement today [...]
Positive FDA Meeting Outlines Path Ahead for Akari Therapeutics’s Coversin in Hematopoietic Stem Cell Transplant-Related Thrombotic Microangiopathy (HSCT-TMA)
13/03/2019
HSCT-TMA trial in pediatric patients expected to start Q4 2019 following recent FDA feedback NEW YORK and LONDON, March 13, 2019 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), a biopharmaceutical company [...]
Oncology Venture rearranges its financing agreement with EHGOS (Alpha Blue Ocean)
13/03/2019
Press release Hoersholm, Denmark, March 13, 2019 – Oncology Venture A/S (Nasdaq First North Stockholm: OV.ST) today announces a modification of the conditions of the financing agreement entered into with European High [...]
Veradigm™ Strengthens its Health Plan and Analytics Solutions by Finalizing Partnership with Pulse8
13/03/2019
CHICAGO, March 13, 2019 (GLOBE NEWSWIRE) -- Veradigm™, an Allscripts (NASDAQ: MDRX), business unit, announced today that it has strengthened its strategic relationship with Pulse8, a leader in healthcare analytics and [...]
Cedars Sinai Uses AlloSure in Tocilizumab Trial
13/03/2019
Cedars Sinai enrolls first patient in a study that uses AlloSure to characterize patient response to therapy BRISBANE, Calif., March 13, 2019 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a molecular diagnostics [...]
ALGENEX appoints new Strategic Advisory Board (SAB)
13/03/2019
PRESS RELEASE ALGENEX appoints new Strategic Advisory Board (SAB) Advisors include recognized industry leaders in international healthcare Madrid (Spain), March 13, 2019 – ALGENEX SL (the “company”), a private [...]
AIT Therapeutics to Participate at Two Investor Conferences in March
13/03/2019
GARDEN CITY, N.Y., and REHOVOT, Israel, March 13, 2019 (GLOBE NEWSWIRE) -- AIT Therapeutics, Inc. (OTCQB: AITB), a clinical-stage medical device and biopharmaceutical company focused on developing inhaled Nitric Oxide ( [...]
Proteon Therapeutics Announces Fourth Quarter and Full-Year 2018 Financial Results
13/03/2019
WALTHAM, Mass., March 13, 2019 (GLOBE NEWSWIRE) -- Proteon Therapeutics, Inc. (Nasdaq: PRTO), a company developing novel, first-in-class pharmaceuticals to address the medical needs of patients with kidney and vascular [...]
Tauriga Sciences Inc. Further Increases its Production of Tauri-Gum Inventory to Support its Ongoing Commercial Launch
13/03/2019
New York, NY, March 13, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), engaged in building its business through the development, distribution, and [...]
Solid Biosciences Reports Fourth Quarter and Fiscal Year 2018 Financial Results and Provides Business Update
13/03/2019
–Activities underway to commence dosing of second cohort of patients in the IGNITE DMD clinical trial at 2E14 vg/kg of SGT-001– CAMBRIDGE, Mass., March 13, 2019 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (NASDAQ: SLDB) [...]
KemPharm Provides Update on APADAZ® Formulary Adoption
13/03/2019
Conference Call Scheduled for Today, Wednesday, March 13, 2019 at 8:30 a.m. ET Highlights: According to MMIT estimates, the authorized generic for APADAZ has unrestricted formulary access for 91% of Commercial lives and [...]
Vaccinex Reports Fourth Quarter 2018 Financial Results and Provides Corporate Update
13/03/2019
Initial data from ongoing open label study of pepinemab (VX15/2503) in combination with avelumab in non-small cell lung cancer expected in 2Q 2019 Enrollment in cohort B of the Phase 2 SIGNAL Huntington’s disease trial [...]
Assembly Biosciences to Participate in the Jefferies 2019 HBV Summit
13/03/2019
SAN FRANCISCO, March 13, 2019 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (NASDAQ: ASMB), a clinical-stage biotechnology company developing innovative therapeutics targeting hepatitis B virus (HBV) and diseases [...]
Anavex Life Sciences to Present at the 31st Annual ROTH Conference 2019
13/03/2019
NEW YORK, March 13, 2019 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of [...]
SunGen Pharma and Athenex Pharmaceutical Division Announce Busulfan Injection Product Launch
13/03/2019
PRINCETON, N.J., March 13, 2019 (GLOBE NEWSWIRE) -- SunGen Pharma, a privately held specialty pharmaceutical company which develops, contract manufactures, and sells pharmaceutical finished products, today announced the [...]

Pages